Precision starts with Preparation
Our Mission
To democratize access to precision oncology by enabling faster, more inexpensive, and more reliable blood-based cancer detection through automated liquid biopsy sample preparation.
About Us
Precision starts with preparation
Avant Genomics is developing a first-of-its kind platform that automates liquid biopsy sample preparation for blood-based cancer detection. We are building a future where liquid biopsy isn't limited by workflow bottlenecks, making blood-based cancer detection faster, more accurate, and more accessible for labs everywhere.
Our enclosed fluidic cartridge and benchtop instruments fully automate the preparation process – dozens of hands-on steps to just two: load the sample, remove the cartridge. The system integrates DNA enrichment and purification, in a closed, 12-plex cartridge, enabling:
- >90% reduction in manual labor
- >80% cost savings vs. conventional methods
- Superior DNA recovery and consistency
- Scalability from research labs to clinical testing environments
Team
Deep Expertise. Bold Vision. One Shared Mission.
News
September 19, 2025
Avant welcomes George Golumbeski as a Business Development Advisor
George brings decades of experience in the cancer detection sector, with previous business development roles at Grail, Celgene, and Novartis.
September 18, 2025
Avant selected as one of the finalists for Cville BioHub's BioSpark pitch event
Avant was honored to share the stage with 8 other innovative life sciences companies in the region at this year's BioSpark event!
Irving Theater at CODE
August 27, 2025
The Avant team moves into North Fork Commonwealth BioAccelerator
Avant's R&D team is 1 of the first 6 resident companies at the new Accelerator, lead by Cville BioHub and Nikki Hastings.
Read More
August 14, 2025
Avant welcomes Kellie Hotz to the team as the Head of Marketing
Kellie is a communications strategist with >20 years of experience shaping brand, market dev, and investor messaging for global healthcare and life science companies.
August 10, 2025
Avant welcomes Ben Paysour as the new Director of Engineering
Ben is a seasoned engineering leader with a track record of driving innovation and excellence in technology development.
May 14, 2025
Avant awarded Innovator of the Year by Charlottesville Business Innovation Council
The award celebrates creativity and resourcefulness. Huge thank you to Tracey Green and the entire CBIC team for the recognition of our hard work!
May 12, 2025
Avant in the press: UVA Today interview with Avant founders Rachelle & Renna
Whitelaw Reid shares an interview with Avant co-founders Rachelle and Renna about the founding of the biotech company at UVA.
April 27, 2025
Avant represents UVA at the 1st inaugural Southeast Ventures Showcase
Avant was selected as one of only 8 University-affiliated companies to pitch at this first of its kind showcase in Nashville, TN.
April 27, 2025
Avant receives a Phase I NSF SBIR for automated liquid biopsy sample preparation
This award will accelerate the development of our platform designed to reduce DNA loss, improve reproducibility, and lower costs to labs. Read more here.
April 27, 2025
Avant is selected as 1 of 10 finalists to participate in VA's Startup World Cup
Avant was honored to participate alongside 10 incredible VA-based companies. Click the link to watch our CEO, Rachelle, pitch at 1:36:18 !
March 3, 2025
Avant selected as TitletownTech Startup Combine finalist
Selected to participate as 1 of only 7 startups in the U.S. to participate out of over 1,000 entries. Read more about Avant's participation here!
Watch the full eventPartnership Opportunities
Strategic Partnerships
At Avant Genomics, we value strategic partnerships with corporate industry, academic and government research institutions, and hospital and reference laboratories. Collaboration drives innovation. We invite you to join us.
Explore PartnershipsInvestment Opportunities
Support our mission to enable precision medicine, beginning in the laboratory. We value investment partners who share our vision to bolster blood-based cancer detection, starting in the laboratory.
Support Avant Genomics